Journal Guide

Drug and Alcohol Dependence is an international journal devoted to publishing original research, scholarly reviews, commentaries, and policy analyses in the area of drug, alcohol and tobacco use and dependence. Articles range from studies of the chemistry of substances of abuse, their actions at molecular and cellular sites, in vitro and in vivo investigations of their biochemical, pharmacological and behavioural actions, laboratory-based and clinical research in humans, substance abuse treatment and prevention research, and studies employing methods from epidemiology, sociology, and economics.The rationale for this extensive coverage is the conviction that drug, alcohol and tobacco use/dependence cannot be understood in their entirety from a single perspective and that without an understanding of other areas of research, studies by individual investigators may be limited. The goal of the journal is to provide researchers, clinicians, and policy makers access to material from all perspectives in a single journal in a format that is understandable and which has received rigorous editorial review. The hope of its editors is to promote mutual understanding of the many facets of drug abuse to the benefit of all investigators involved in drug and alcohol research, and to facilitate the transfer of scientific findings to successful treatment and prevention practices.The accepted abbreviation for Drug and Alcohol Dependence for bibliographic citation is Drug Alcohol Depend.Drug and Alcohol Dependence is currently being distributed to all the members of the College on Problems of Drug Dependence (CPDD), the oldest scientific organization in the United States concerned with research on problems of drug dependence. Members of the CPDD are provided with both the print version as well as access to the full text of the current issue and back issues dating back to Vol. 46, Issue no. 1 of the online version as a benefit of membership.

Drug and Alcohol Review is an international meeting ground for the views, expertise and experience of all those involved in studying alcohol, tobacco and drug problems. Contributors to the Journal examine and report on alcohol and drug use from a wide range of clinical, biomedical, epidemiological, psychological and sociological perspectives. Drug and Alcohol Review particularly encourages the submission of papers which have a harm reduction perspective. However, all philosophies will find a place in the Journal: the principal criterion for publication of papers is their quality.

Drug and Chemical Toxicology publishes full-length research papers, review articles and short communications that encompass a broad spectrum of toxicological data surrounding risk assessment and harmful exposure. Manuscripts are considered according to their relevance to the journal.

For nearly 50 years, DTB has provided rigorous and independent evaluations of, and practical advice on, individual treatments and the overall management of disease for doctors, pharmacists and other healthcare professionals. DTB was started in 1962. From the outset, it has provided healthcare professionals with independent, clear, reliable information and advice to help ensure patients get the best care. DTB conclusions represent a synthesis of the best available medical evidence with opinions from a wide range of commentators. Published monthly by BMJ, DTB is wholly independent of industry, Government and regulatory authorities and does not carry any display advertising or accept any form of commercial sponsorship.DTB provides articles based on a synthesis of evidence with opinions from a wide range of specialist and generalist commentators, typically over 40 individuals and organisations for each article. Over the years, DTB has initiated successful campaigns for the removal or restriction of medicines that it could not recommend, prompted withdrawal of excessive promotional claims and exposed fundamental weaknesses in certain prescribing practice.Surveys of our readership have consistently shown that readers find DTB authoritative and influential in relation to their decisions, recommendations or advice on treatments. These are just a few of the examples of why DTB is regarded as an indispensable part of evidence-based clinical practice and has been described as both essential reading for practising doctors and as a key information source by the House of Commons Health Select Committee in the UK.

Stay up to date with the latest developments in therapeutics by reading the world’s most respected source of authoritative drug information. For over 50 years Drugs has been the definitive journal of drugs and therapeutics, promoting optimum pharmacotherapy by publishing reviews and original clinical research authored by leading international clinicians and researchers to support clinical decision-making.   

Through a rigorous and comprehensive program of peer-reviewed evaluations, Drugs provides detailed and objective analysis covering the full spectrum of new and established drug therapies in all disease areas.

As a hybrid journal, Drugs does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require (more information).

Drugs offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content (more information).

For 30 years Drugs & Aging has been delivering essential information on the most important aspects of drug therapy to researchers and healthcare professionals involved in the care of older patients.

Through a program of reviews and original research articles, the journal addresses major issues relating to drug therapy in older adults, including the management of specific diseases or disorders, particularly those associated with aging, age-related physiological changes impacting drug therapy, and issues related to drug utilization and prescribing.

As a hybrid journal, Drugs & Aging does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require (more information).

Drugs & Aging offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content (more information).

Drugs & Therapy Perspectives provides concise, authoritative review articles to aid drug formulary and prescribing decisions. It is a digest of the latest drug knowledge covering the most important aspects of clinical therapeutics, including:Questions and answers on the clinical use of drugs.Comparisons of the features of various drugs, using differential feature tables.Current thinking on disease management.Step-by-step clinical decision-making, illustrated with patient care algorithms.First reports of serious adverse drug reactions.Clinically useful pharmacodynamics and pharmacokinetics.Developments in pharmacoeconomics and other research that have a bearing on clinical practice.All material is prepared by Adis editors and medical writers, unless otherwise noted. The preparation of material is not supported by any external funding. All review articles are subject to peer review by members of the journal's international editorial board and/or other experts.

Drugs - Real World Outcomes targets research involving the use of real-world data to evaluate health outcomes and inform healthcare decision-making, with a particular focus on healthcare-related 'big data'. Drugs - Real World Outcomes has a broad scope, encompassing studies investigating drug utilisation, patterns of prescribing, pharmacovigilance, treatment guideline adherence, benefit-risk assessments, comparative effectiveness and economic analyses.

Drugs and Alcohol Today journal is committed to bringing together scientific research as well as practitioner and policy reports on the social, economic, and political aspects of alcohol and other drugs.

Drugs: education, prevention & policy is a refereed journal which aims to provide a forum for communication and debate between policy makers, practitioners and researchers concerned with social and health policy responses to legal and illicit drug use and drug-related harm. The journal publishes multi-disciplinary research papers, commentaries and reviews on policy, prevention and harm reduction issues regarding the use and misuse of alcohol, tobacco and other drugs. It is journal policy to encourage submissions which reflect different cultural, historical and theoretical approaches to the development of policy and practice.The Editor welcomes contributions based on original research, policy discussion, evaluations of policy and practice, literature reviews, and papers which examine historical and cultural aspects of substance use and social responses to use and problematic use.Short contributions are also welcome for two new sections in the journal:Policy News will aim to provide information and discussion on current policy developments and issues of national or international importance in prevention or harm reductionConference Reports is intended to provide brief accounts, from the contributor’s point of view, of the themes and outcomes from national or international conferences.Read More: http://informahealthcare.com/page/dep/Description.

The Dubai Diabetes and Endocrinology Journal welcomes original contributions on all aspects of diabetes, endocrinology, and metabolism. Taking into account that diabetes has become a pandemic, the journal provides a platform for worldwide communication and scientific exchange to researchers and clinicians dealing with diabetes. The focus of the journal lies on the publication of papers on morphological, biochemical, physiological, pathophysiological, and clinical aspects of research on diabetes and metabolism. In addition to research articles, further types of papers such as review articles, case reports, reviews, meta-analyses, letters, editorials, and commentaries make the journal a comprehensive and interesting read. The researcher and practitioner who seeks to stay up to date on the developments in the fields of diabetes and metabolism will find a wealth of information in the Dubai Diabetes and Endocrinology Journal.

The mission of the Dubai Medical Journal is to encourage innovative research by promoting original scientific research in the fields of medicine, health sciences, nursing, pharmaceuticals, and laboratory work in addition to women’s and children’s health. Nonclinical subjects related to medicine, especially ethics and complementary medicine as well as social and cultural observations, are also covered. As international as Dubai itself, the journal offers a global perspective, but also focuses on the United Arab Emirates. Partnerships with local and international medical and health authorities are envisaged.
The journal facilitates the dissemination of information through research articles, review articles, case reports, editorials, letters, book reviews, meta-analyses and commentaries. An educational corner will help to ensure continuous professional development and education. Besides this, the journal also offers a platform for controversies, mythology, and much more.

DYNAMIS is an international journal devoted to the history of medicine, health and science, founded in 1981, that pays special attention to novel and interdisciplinary historiographic perspectives. It offers original, double peer-reviewed research studies (articles, notes or documents) and reviews in languages of the European Union.

DYSLEXIA provides reviews and reports of research, assessment and intervention practice. In many fields of enquiry theoretical advances often occur in response to practical needs; and a central aim of the journal is to bring together researchers and practitioners in the field of dyslexia, so that each can learn from the other. Interesting developments, both theoretical and practical, are being reported in many different countries: DYSLEXIA is a forum in which a knowledge of these developments can be shared by readers in all parts of the world. The scope of the journal includes relevant aspects of.

Dysphagia is a multidisciplinary journal devoted to swallowing and its disorders. The journal's purpose is to provide an international source of information to physicians and other health professionals interested in this emerging field. Its scope includes all aspects of normal and dysphagic ingestion involving the mouth, pharynx, and esophagus. Accordingly, the journal will draw on expertise from a variety of disciplines including gastroenterology, neurology, otolaryngology, radiology, dentistry, rehabilitation medicine, speech pathology, nursing, dietetics, medical administration, and the basic biomedical sciences. The journal is intended to contribute to the development of this field by fostering communication between interested professionals, by setting forth existing knowledge, and by stimulating further research. Submission of contributions that advance the understanding of normal swallowing as well as those related to dysphagia, its diagnosis, and its clinical management, is encouraged. Dysphagia has be